These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 11237490)

  • 1. Vascular endothelial growth factor (VEGF)--a valuable serum tumour marker in patients with colorectal cancer?
    Broll R; Erdmann H; Duchrow M; Oevermann E; Schwandner O; Markert U; Bruch HP; Windhövel U
    Eur J Surg Oncol; 2001 Feb; 27(1):37-42. PubMed ID: 11237490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating vascular endothelial growth factor in patients with colorectal cancer.
    Fujisaki K; Mitsuyama K; Toyonaga A; Matsuo K; Tanikawa K
    Am J Gastroenterol; 1998 Feb; 93(2):249-52. PubMed ID: 9468253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemiluminometric determination of tissue polypeptide antigen (TPA), cancer antigen 15-3 (CA 15-3), carcinoembryonic antigen (CEA) in comparison with vascular endothelial growth factor (VEGF) in follow-up of breast cancer.
    Findeisen R; Albrecht S; Richter B; Deutschmann K; Zimmermann T; Distler W
    Luminescence; 2000; 15(5):283-9. PubMed ID: 11038485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-operative serum vascular endothelial growth factor can select patients for adjuvant treatment after curative resection in colorectal cancer.
    Chin KF; Greenman J; Gardiner E; Kumar H; Topping K; Monson J
    Br J Cancer; 2000 Dec; 83(11):1425-31. PubMed ID: 11076648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
    Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
    Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of serum vascular endothelial growth factor in colorectal cancer patients: correlation with clinicopathological factors and tumor markers.
    Takeda A; Shimada H; Imaseki H; Okazumi S; Natsume T; Suzuki T; Ochiai T
    Oncol Rep; 2000; 7(2):333-8. PubMed ID: 10671682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of vascular endothelial growth factor (VEGF) concentration in serum of patients with colorectal carcinoma].
    Broll R; Erdmann H; Windhövel U; Duchrow M; Strik MW
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):315-8. PubMed ID: 14518267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of plasma vascular endothelial growth factor in patients with colorectal cancer.
    Nakayama Y; Sako T; Shibao K; Okazaki K; Rempo N; Onitsuka K; Minagawa N; Akahane K; Nagashima N; Nagata N; Itoh H
    Anticancer Res; 2002; 22(4):2437-42. PubMed ID: 12174940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between plasma levels of vascular endothelial growth factor and serum levels of interleukin-12 in patients with colorectal cancer.
    Nakayama Y; Sako T; Shibao K; Onitsuka K; Nagashima N; Hirata K; Nagata N; Itoh H
    Anticancer Res; 2000; 20(6A):4097-102. PubMed ID: 11131678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?
    George ML; Eccles SA; Tutton MG; Abulafi AM; Swift RI
    Clin Cancer Res; 2000 Aug; 6(8):3147-52. PubMed ID: 10955796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study Group.
    Werther K; Christensen IJ; Brünner N; Nielsen HJ
    Eur J Surg Oncol; 2000 Nov; 26(7):657-62. PubMed ID: 11078612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma vascular endothelial but not fibroblast growth factor levels correlate with colorectal liver mestastasis vascularity and volume.
    Davies MM; Jonas SK; Kaur S; Allen-Mersh TG
    Br J Cancer; 2000 Mar; 82(5):1004-8. PubMed ID: 10737380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma.
    Shang ZJ; Li JR; Li ZB
    Int J Oral Maxillofac Surg; 2002 Oct; 31(5):495-8. PubMed ID: 12418564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma: a possible diagnostic tool for lymph node metastasis.
    Tamura M; Ohta Y
    Cancer; 2003 Sep; 98(6):1217-22. PubMed ID: 12973845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic relevance of serum vascular endothelial growth factor in ovarian cancer.
    Oehler MK; Caffier H
    Anticancer Res; 2000; 20(6D):5109-12. PubMed ID: 11326678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing tissue concentration of vascular endothelial growth factor in colorectal carcinoma.
    Ono T; Miki C
    Am J Gastroenterol; 2000 Apr; 95(4):1062-7. PubMed ID: 10763960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of serum VEGF in women with ovarian tumors.
    Oehler MK; Caffier H
    Anticancer Res; 1999; 19(4A):2519-22. PubMed ID: 10470186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum vascular endothelial growth factor is often elevated in disseminated cancer.
    Salven P; Mänpää H; Orpana A; Alitalo K; Joensuu H
    Clin Cancer Res; 1997 May; 3(5):647-51. PubMed ID: 9815732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with malignant bone tumors.
    Holzer G; Obermair A; Koschat M; Preyer O; Kotz R; Trieb K
    Med Pediatr Oncol; 2001 Jun; 36(6):601-4. PubMed ID: 11344490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.